DFCI/BCH-HITO quality improvement project for hematologic malignancies: implementation and validation of MRD by flow cytometry in pediatric acute leukemia treatment protocols

Acute leukemias have an incidence rate of 75.3 per million people per year and represent 50.8% of childhood cancers in Mexico. Despite improved access to treatment through a fund for catastrophic illnesses for almost a decade, the population-based 5-year survival rate remains u003c50% for acute